JP2010533478A5 - - Google Patents

Download PDF

Info

Publication number
JP2010533478A5
JP2010533478A5 JP2010516305A JP2010516305A JP2010533478A5 JP 2010533478 A5 JP2010533478 A5 JP 2010533478A5 JP 2010516305 A JP2010516305 A JP 2010516305A JP 2010516305 A JP2010516305 A JP 2010516305A JP 2010533478 A5 JP2010533478 A5 JP 2010533478A5
Authority
JP
Japan
Prior art keywords
gamma secretase
seq
ledaefrhds
lvml
substrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2010516305A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010533478A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from US12/172,978 external-priority patent/US20090023158A1/en
Publication of JP2010533478A publication Critical patent/JP2010533478A/ja
Publication of JP2010533478A5 publication Critical patent/JP2010533478A5/ja
Withdrawn legal-status Critical Current

Links

JP2010516305A 2007-07-13 2008-07-14 ガンマセクレターゼの阻害剤の基質特異性を同定するための組成物および方法 Withdrawn JP2010533478A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US94973807P 2007-07-13 2007-07-13
US12/172,978 US20090023158A1 (en) 2007-07-13 2008-07-14 Compositions and Methods for Identifying Substrate Specificity of Inhibitors of Gamma Secretase
PCT/US2008/070012 WO2009012237A1 (en) 2007-07-13 2008-07-14 Compositions and methods for identifying substrate specificity of inhibitors of gamma secretase

Publications (2)

Publication Number Publication Date
JP2010533478A JP2010533478A (ja) 2010-10-28
JP2010533478A5 true JP2010533478A5 (https=) 2011-09-01

Family

ID=39739883

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010516305A Withdrawn JP2010533478A (ja) 2007-07-13 2008-07-14 ガンマセクレターゼの阻害剤の基質特異性を同定するための組成物および方法

Country Status (5)

Country Link
US (2) US20090023158A1 (https=)
EP (1) EP2183598A1 (https=)
JP (1) JP2010533478A (https=)
CA (1) CA2692604A1 (https=)
WO (1) WO2009012237A1 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7910324B2 (en) * 2007-06-08 2011-03-22 Eisai R&D Management Co., Ltd. Method of screening for compounds which affect the processing of EphA4 by γ-secretase
US20090191580A1 (en) * 2007-07-19 2009-07-30 Eisai R & D Management Co., Ltd. METHOD OF SCREENING USING c-MET, A NOVEL SUBSTRATE FOR GAMMA-SECRETASE
JPWO2009017234A1 (ja) * 2007-08-01 2010-10-28 エーザイ・アール・アンド・ディー・マネジメント株式会社 γ−セクレターゼの新規基質c−Retを利用したスクリーニング方法
US20090163594A1 (en) * 2007-10-31 2009-06-25 Elan Pharmaceuticals, Inc. Triple Assay System for Identifying Substrate Selectivity of Gamma Secretase Inhibitors
JP5580598B2 (ja) * 2007-11-15 2014-08-27 エーザイ・アール・アンド・ディー・マネジメント株式会社 γ−セクレターゼの新規基質EphA7を利用したスクリーニング方法
US7892769B2 (en) * 2007-11-30 2011-02-22 Eisai R&D Management Co., Ltd. Processing of EphA4 polypeptide by γ-secretase activity
JP6059017B2 (ja) 2010-12-17 2017-01-11 エーザイ・アール・アンド・ディー・マネジメント株式会社 ゼラチナーゼによるEphA4の切断反応を指標としたスクリーニング方法
JP5961608B2 (ja) 2011-04-25 2016-08-02 エーザイ・アール・アンド・ディー・マネジメント株式会社 EphA4細胞外ドメインの測定による認知機能障害を伴う神経系疾患の検出方法
ES2660969T5 (es) 2012-06-22 2021-09-03 Gentium S R L Método basado en euglobulina para determinar la actividad biológica de defibrotida
EP3026122A1 (en) 2014-11-27 2016-06-01 Gentium S.p.A. Cellular-based method for determining the potency of defibrotide
US11732260B2 (en) * 2018-03-02 2023-08-22 Ionis Pharmaceuticals, Inc. Compounds and methods for the modulation of amyloid-β precursor protein
AR119303A1 (es) 2019-07-01 2021-12-09 Eisai R&D Man Co Ltd Anticuerpo anti-epha4 humano
WO2021174075A1 (en) * 2020-02-27 2021-09-02 Adeptrix Corp. Multiplexed bead-based analytical assays
US20230174612A1 (en) * 2020-04-09 2023-06-08 The Regents Of The University Of California Notch receptors with zinc finger-containing transcriptional effector
CA3189922A1 (en) 2020-07-28 2022-02-03 Ionis Pharmaceuticals, Inc. Compounds and methods for reducing app expression

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5604102A (en) 1992-04-15 1997-02-18 Athena Neurosciences, Inc. Methods of screening for β-amyloid peptide production inhibitors
US5441870A (en) 1992-04-15 1995-08-15 Athena Neurosciences, Inc. Methods for monitoring cellular processing of β-amyloid precursor protein
US5766846A (en) * 1992-07-10 1998-06-16 Athena Neurosciences Methods of screening for compounds which inhibit soluble β-amyloid peptide production
US5605811A (en) 1992-10-26 1997-02-25 Athena Neurosciences, Inc. Methods and compositions for monitoring cellular processing of beta-amyloid precursor protein
AU702293B2 (en) 1993-10-27 1999-02-18 Athena Neurosciences, Inc. Transgenic animals harboring APP allele having Swedish mutation
DE10131899A1 (de) * 2001-07-04 2003-02-27 Boehringer Ingelheim Pharma In vitro-Screening-Assay für gamma-Secretase
WO2007058987A1 (en) * 2005-11-10 2007-05-24 Bristol-Myers Squibb Company Methods of identifying compounds that inhibit notch cleavage
US20090163594A1 (en) * 2007-10-31 2009-06-25 Elan Pharmaceuticals, Inc. Triple Assay System for Identifying Substrate Selectivity of Gamma Secretase Inhibitors

Similar Documents

Publication Publication Date Title
JP2010533478A5 (https=)
JP2013503110A5 (https=)
JP2008237210A5 (https=)
WO2010123290A3 (ko) 체내 지속성을 유지함으로 체내 반감기가 증가된 단백질 또는 펩티드 융합체, 및 이를 이용하여 체내 반감기를 증가시키는 방법
WO2017070256A8 (en) Method for screening inhibitors of ras
WO2009129311A3 (en) Somatostatin receptor 2 antagonists
WO2007148224A8 (en) Polypeptide
NZ597692A (en) Anti-IGF antibodies
JP2010519289A5 (https=)
JP2013505287A5 (https=)
JP2021505620A5 (https=)
WO2009079212A3 (en) Linked peptide fluorogenic biosensors
JP2016513471A5 (https=)
WO2005119251A3 (en) Novel means and methods for the treatment of hearing loss and phantom hearing
WO2009107971A3 (ko) 포스파티딜세린과 특이적으로 결합하는 폴리펩티드 및 이의 용도
WO2018175581A8 (en) A GENETICALLY MODIFIED MOUSE EXPRESSING HUMAN APOE4 AND MOUSE Trem2 p.R47H AND METHODS OF USE THEREOF
JP2005512547A5 (https=)
ATE488252T1 (de) Erhöhte transduktion mit abc- transportersubstratenhemmern
WO2008142664A3 (en) Exposed thymidine kinase 1 peptides, ligands and methods employing the same
JP2006158399A5 (ja) 細胞増殖抑制タンパク質並びにそれを用いる細胞増殖抑制剤、癌診断薬及び癌治療剤
EA200801856A1 (ru) Система привода для манипулятора (варианты)
WO2012162637A3 (en) Vaccine adjuvants from self-assembling peptides
JP2014534173A5 (https=)
JP2009067947A5 (https=)
Heidmeier et al. A single amino acid substitution in the measles virus F2 protein reciprocally modulates membrane fusion activity in pathogenic and oncolytic strains